Provided by Tiger Trade Technology Pte. Ltd.

Bausch + Lomb Corp.

18.14
+0.25501.43%
Volume:26.47K
Turnover:476.07K
Market Cap:6.46B
PE:-37.68
High:18.14
Open:17.94
Low:17.87
Close:17.88
52wk High:18.92
52wk Low:13.77
Shares:356.38M
Float Shares:45.50M
Volume Ratio:2.22
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4814
EPS(LYR):-1.0200
ROE:-2.52%
ROA:1.83%
PB:1.01
PE(LYR):-17.78

Loading ...

Bausch + Lomb publishes new research on en Vista Aspire IOLs

TIPRANKS
·
2 hours ago

Bausch + Lomb Study Finds enVista Aspire IOLs Deliver Strong Distance, Intermediate Vision in Real-World Use

Reuters
·
2 hours ago

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results

Reuters
·
Aug 25

Bausch + Lomb Advances Dual-Action Dry Eye Drop into Phase 3 After Phase 2 Day 15 Endpoint Win

Reuters
·
Aug 25

Baxter Stock And 2 MedTech Turnaround Plays Retail Investors Are Watching

Simply Wall St.
·
Aug 17

Bausch + Lomb Files Form 3 Disclosing Director Thomas Appio Stake of 27,583 Shares

Reuters
·
Aug 15

Bausch + Lomb SVP, Controller and CAO Frederick Munsch Sells 52,900 Common Shares Worth $887,662

Reuters
·
Aug 13

Bausch + Lomb Names Thomas Appio Board Chair in Amended Filing, Replacing Brent Saunders

Reuters
·
Aug 12

Bausch + Lomb Director Andrew C. Von Eschenbach Sells 18,559 Common Shares for $306,709.22

Reuters
·
Aug 11

Press Release: Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board

Dow Jones
·
Aug 06

Did Bausch + Lomb’s Stronger Q2 and Higher 2026 Revenue Guidance Just Shift BLCO’s Investment Narrative?

Simply Wall St.
·
Aug 04

Analysts Conflicted on These Healthcare Names: Bausch + Lomb Corporation (BLCO) and Pharming Group (PHAR)

TIPRANKS
·
Jul 31

UBS Adjusts Price Target on Bausch + Lomb to $23 From $21, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Conmed Q2 Sales, Adjusted Profit Beat on Organinc Platform Growth

Reuters
·
Jul 30

Canada's Bausch Health Q2 Results Beat Estimates; Raises 2026 Outlook

Reuters
·
Jul 30

Glaukos Q2 Sales Jump 50%; Raises Net Sales Forecast

Reuters
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bausch + Lomb Corporation (BLCO) and Curis (CRIS)

TIPRANKS
·
Jul 30

Bausch + Lomb Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Bausch + Lomb Q2 Revenue Beats on Surgical Segment Growth; Lifts Outlook

Reuters
·
Jul 29